InvestorsObserver
×
News Home

Where Does KemPharm Inc (KMPH) Stock Fall in the Biotechnology Field After It Is Down -1.30% This Week?

Thursday, November 17, 2022 11:29 AM | InvestorsObserver Analysts

Mentioned in this article

Where Does KemPharm Inc (KMPH) Stock Fall in the Biotechnology Field After It Is Down -1.30% This Week?

KemPharm Inc (KMPH) is near the top in its industry group according to InvestorsObserver. KMPH gets an overall rating of 70. That means it scores higher than 70 percent of stocks. KemPharm Inc gets a 83 rank in the Biotechnology industry. Biotechnology is number 38 out of 148 industries.

Overall Score - 70
KMPH has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on KMPH!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With KemPharm Inc Stock Today?

KemPharm Inc (KMPH) stock is higher by 3.64% while the S&P 500 is down -1.04% as of 11:29 AM on Thursday, Nov 17. KMPH has gained $0.16 from the previous closing price of $4.39 on volume of 213,064 shares. Over the past year the S&P 500 is down -16.44% while KMPH is down -45.51%. KMPH lost -$1.02 per share the over the last 12 months. Click Here to get the full Stock Report for KemPharm Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App